Waters Corporation $WAT Shares Purchased by Eads & Heald Wealth Management

Eads & Heald Wealth Management lifted its stake in Waters Corporation (NYSE:WAT) by 4.0% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,282 shares of the medical instruments supplier’s stock after purchasing an additional 49 shares during the quarter. Eads & Heald Wealth Management’s holdings in Waters were worth $447,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Fenimore Asset Management Inc raised its holdings in shares of Waters by 4.0% in the second quarter. Fenimore Asset Management Inc now owns 243,780 shares of the medical instruments supplier’s stock worth $85,089,000 after buying an additional 9,292 shares during the last quarter. 111 Capital purchased a new position in Waters in the 2nd quarter worth $326,000. QRG Capital Management Inc. raised its stake in Waters by 37.1% in the 2nd quarter. QRG Capital Management Inc. now owns 2,251 shares of the medical instruments supplier’s stock worth $786,000 after acquiring an additional 609 shares during the last quarter. Stock Yards Bank & Trust Co. grew its stake in Waters by 2.5% during the 2nd quarter. Stock Yards Bank & Trust Co. now owns 2,226 shares of the medical instruments supplier’s stock valued at $777,000 after purchasing an additional 55 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Waters by 12.6% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,021 shares of the medical instruments supplier’s stock valued at $2,800,000 after purchasing an additional 896 shares during the period. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Stock Performance

NYSE WAT opened at $328.95 on Monday. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56. The stock has a 50-day moving average of $296.92 and a 200 day moving average of $325.01. The stock has a market capitalization of $19.58 billion, a price-to-earnings ratio of 29.66, a PEG ratio of 3.06 and a beta of 1.04.

Waters (NYSE:WAT) last announced its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. The firm had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. Waters had a return on equity of 38.60% and a net margin of 21.71%.The business’s revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the firm posted $2.63 EPS. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Sell-side analysts anticipate that Waters Corporation will post 12.86 EPS for the current fiscal year.

Wall Street Analyst Weigh In

WAT has been the subject of a number of research reports. Robert W. Baird decreased their target price on Waters from $374.00 to $352.00 and set an “outperform” rating for the company in a report on Wednesday, July 16th. Scotiabank restated a “sector outperform” rating and set a $465.00 price objective on shares of Waters in a research note on Friday, July 11th. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on shares of Waters and gave the stock a “hold” rating in a research note on Tuesday, August 5th. Wells Fargo & Company decreased their target price on shares of Waters from $330.00 to $315.00 and set an “equal weight” rating for the company in a research report on Tuesday, August 5th. Finally, Wall Street Zen lowered shares of Waters from a “buy” rating to a “hold” rating in a report on Saturday, July 26th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, Waters has a consensus rating of “Hold” and a consensus target price of $380.43.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.